FX201

· Pacira Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FX201, covering 2025-03-17 to 2025-03-17. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety and Tolerability of FX201 in Patients with Osteoarthritis of the Knee [Phase 1]